메뉴 건너뛰기




Volumn 317, Issue 2, 2012, Pages 184-191

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1

Author keywords

Chemoresistance; Docetaxel; Lung adenocarcinoma; MiR 100; Plk1

Indexed keywords

CISPLATIN; DOCETAXEL; MESSENGER RNA; MICRORNA; MICRORNA 100; UNCLASSIFIED DRUG;

EID: 84856595853     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.024     Document Type: Article
Times cited : (85)

References (41)
  • 1
    • 0032933622 scopus 로고    scopus 로고
    • Taxol suppresses dynamics of individual microtubules in living human tumor cells
    • Yvon A.M., Wadsworth P., Jordan M.A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell 1999, 10(4):947-959.
    • (1999) Mol. Biol. Cell , vol.10 , Issue.4 , pp. 947-959
    • Yvon, A.M.1    Wadsworth, P.2    Jordan, M.A.3
  • 2
    • 28144445570 scopus 로고    scopus 로고
    • Docetaxel: a review of its use in metastatic breast cancer
    • Lyseng-Williamson K.A., Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs 2005, 65(17):2513-2531.
    • (2005) Drugs , vol.65 , Issue.17 , pp. 2513-2531
    • Lyseng-Williamson, K.A.1    Fenton, C.2
  • 3
    • 3142752689 scopus 로고    scopus 로고
    • Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
    • Hopper-Borge E., Chen Z.S., Shchaveleva I., Belinsky M.G., Kruh G.D. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res. 2004, 64(14):4927-4930.
    • (2004) Cancer Res. , vol.64 , Issue.14 , pp. 4927-4930
    • Hopper-Borge, E.1    Chen, Z.S.2    Shchaveleva, I.3    Belinsky, M.G.4    Kruh, G.D.5
  • 5
    • 77649191871 scopus 로고    scopus 로고
    • Microtubules and resistance to tubulin-binding agents
    • Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 2010, 10(3):194-204.
    • (2010) Nat. Rev. Cancer , vol.10 , Issue.3 , pp. 194-204
    • Kavallaris, M.1
  • 6
    • 33846471634 scopus 로고    scopus 로고
    • Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers
    • Ooe A., Kato K., Noguchi S. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. Breast Cancer Res. Treat. 2007, 101(3):305-315.
    • (2007) Breast Cancer Res. Treat. , vol.101 , Issue.3 , pp. 305-315
    • Ooe, A.1    Kato, K.2    Noguchi, S.3
  • 8
    • 33645294070 scopus 로고    scopus 로고
    • Oncomirs - microRNAs with a role in cancer
    • Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6(4):259-269.
    • (2006) Nat. Rev. Cancer , vol.6 , Issue.4 , pp. 259-269
    • Esquela-Kerscher, A.1    Slack, F.J.2
  • 9
    • 33846188098 scopus 로고    scopus 로고
    • MicroRNAs as oncogenes and tumor suppressors
    • Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Bio. 2007, 302(1):1-12.
    • (2007) Dev. Bio. , vol.302 , Issue.1 , pp. 1-12
    • Zhang, B.1    Pan, X.2    Cobb, G.P.3    Anderson, T.A.4
  • 11
    • 77955619456 scopus 로고    scopus 로고
    • MiR-181b Modulates multidrug resistance by targeting BCL2 in human cancer cell lines
    • Zhu W., Shan X., Wang T., Shu Y., Liu P. miR-181b Modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 2010, 127(1):2520-2529.
    • (2010) Int. J. Cancer , vol.127 , Issue.1 , pp. 2520-2529
    • Zhu, W.1    Shan, X.2    Wang, T.3    Shu, Y.4    Liu, P.5
  • 12
    • 77955478900 scopus 로고    scopus 로고
    • MiR-192/miR-215 Influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
    • Boni V., Bitarte N., Cristobal I., Zarate R., Rodriguez J., Maiello E., Garcia-Foncillas J., Bandres E. miR-192/miR-215 Influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol. Cancer Ther. 2010, 9(8):2265-2275.
    • (2010) Mol. Cancer Ther. , vol.9 , Issue.8 , pp. 2265-2275
    • Boni, V.1    Bitarte, N.2    Cristobal, I.3    Zarate, R.4    Rodriguez, J.5    Maiello, E.6    Garcia-Foncillas, J.7    Bandres, E.8
  • 13
    • 66849113786 scopus 로고    scopus 로고
    • MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells
    • Pan Y.Z., Morris M.E., Yu A.M. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol. Pharmacol. 2009, 75(6):1374-1379.
    • (2009) Mol. Pharmacol. , vol.75 , Issue.6 , pp. 1374-1379
    • Pan, Y.Z.1    Morris, M.E.2    Yu, A.M.3
  • 15
    • 79955889222 scopus 로고    scopus 로고
    • MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance
    • Dai Y., Xie C.H., Neis J.P., Fan C.Y., Vural E., Spring P.M. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head Neck 2011, 33(6):786-791.
    • (2011) Head Neck , vol.33 , Issue.6 , pp. 786-791
    • Dai, Y.1    Xie, C.H.2    Neis, J.P.3    Fan, C.Y.4    Vural, E.5    Spring, P.M.6
  • 16
    • 77951945516 scopus 로고    scopus 로고
    • Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
    • Rui W., Bing F., Hai-Zhu S., Wei D., Long-Bang C. Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J. Cell Mol. Med. 2010, 14(1-2):206-214.
    • (2010) J. Cell Mol. Med. , vol.14 , Issue.1-2 , pp. 206-214
    • Rui, W.1    Bing, F.2    Hai-Zhu, S.3    Wei, D.4    Long-Bang, C.5
  • 17
    • 68949159920 scopus 로고    scopus 로고
    • Mechanism of drug resistance identified in human lung adenocarcinoma cell line SPC-A1 selected for resistance to docetaxel
    • Hai S., Long-Bang C. Mechanism of drug resistance identified in human lung adenocarcinoma cell line SPC-A1 selected for resistance to docetaxel. Chin. J. Cancer Res. 2009, 21(3):207-216.
    • (2009) Chin. J. Cancer Res. , vol.21 , Issue.3 , pp. 207-216
    • Hai, S.1    Long-Bang, C.2
  • 18
    • 66749160812 scopus 로고    scopus 로고
    • The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras
    • Tsang W.P., Kwok T.T. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 2009, 30(6):953-959.
    • (2009) Carcinogenesis , vol.30 , Issue.6 , pp. 953-959
    • Tsang, W.P.1    Kwok, T.T.2
  • 19
    • 0034040624 scopus 로고    scopus 로고
    • The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity
    • Yang F., Sarangarajan R., Le Poole I.C., Medrano E.E., Boissy R.E. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J. Invest. Dermatol. 2000, 114(1):157-164.
    • (2000) J. Invest. Dermatol. , vol.114 , Issue.1 , pp. 157-164
    • Yang, F.1    Sarangarajan, R.2    Le Poole, I.C.3    Medrano, E.E.4    Boissy, R.E.5
  • 20
    • 27644488740 scopus 로고    scopus 로고
    • Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo
    • Zhang S.Z., Pan F.Y., Xu J.F., Yuan J., Guo S.Y., Dai G., Xue B., Shen W.G., Wen C.J., Zhao D.H., Li C.J. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol. Cancer Ther. 2005, 4(10):1577-1584.
    • (2005) Mol. Cancer Ther. , vol.4 , Issue.10 , pp. 1577-1584
    • Zhang, S.Z.1    Pan, F.Y.2    Xu, J.F.3    Yuan, J.4    Guo, S.Y.5    Dai, G.6    Xue, B.7    Shen, W.G.8    Wen, C.J.9    Zhao, D.H.10    Li, C.J.11
  • 21
    • 60849131758 scopus 로고    scopus 로고
    • The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo
    • Liu P., Chen L., Huang X. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Cancer Biother. Radiopharm. 2009, 24(1):91-98.
    • (2009) Cancer Biother. Radiopharm. , vol.24 , Issue.1 , pp. 91-98
    • Liu, P.1    Chen, L.2    Huang, X.3
  • 23
    • 0034212385 scopus 로고    scopus 로고
    • Paclitaxel-induced cell death: where the cell cycle and apoptosis come together
    • Wang T.H., Wang H.S., Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000, 88(11):2619-2628.
    • (2000) Cancer , vol.88 , Issue.11 , pp. 2619-2628
    • Wang, T.H.1    Wang, H.S.2    Soong, Y.K.3
  • 24
    • 0036902234 scopus 로고    scopus 로고
    • Regulation of APC-Cdc20 by the spindle checkpoint
    • Yu H. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol. 2002, 14(6):706-714.
    • (2002) Curr. Opin. Cell Biol. , vol.14 , Issue.6 , pp. 706-714
    • Yu, H.1
  • 26
    • 77950395080 scopus 로고    scopus 로고
    • Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells
    • Kastl L., Brown I., Schofield A.C. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. Int. J. Oncol. 2010, 36(5):1235-1241.
    • (2010) Int. J. Oncol. , vol.36 , Issue.5 , pp. 1235-1241
    • Kastl, L.1    Brown, I.2    Schofield, A.C.3
  • 27
    • 0029079267 scopus 로고
    • Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function
    • Golsteyn R.M., Mundt K.E., Fry A.M., Nigg E.A. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol. 1995, 129(6):1617-1628.
    • (1995) J. Cell Biol. , vol.129 , Issue.6 , pp. 1617-1628
    • Golsteyn, R.M.1    Mundt, K.E.2    Fry, A.M.3    Nigg, E.A.4
  • 28
    • 0036256260 scopus 로고    scopus 로고
    • Plk1 promotes nuclear translocation of human Cdc25C during prophase
    • Toyoshima-Morimoto F., Taniguchi E., Nishida E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep. 2002, 3(4):341-348.
    • (2002) EMBO Rep. , vol.3 , Issue.4 , pp. 341-348
    • Toyoshima-Morimoto, F.1    Taniguchi, E.2    Nishida, E.3
  • 29
    • 0035826154 scopus 로고    scopus 로고
    • Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase
    • Toyoshima-Morimoto F., Taniguchi E., Shinya N., Iwamatsu A., Nishida E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 2001, 410(6825):215-220.
    • (2001) Nature , vol.410 , Issue.6825 , pp. 215-220
    • Toyoshima-Morimoto, F.1    Taniguchi, E.2    Shinya, N.3    Iwamatsu, A.4    Nishida, E.5
  • 30
    • 62849123093 scopus 로고    scopus 로고
    • Polo-like kinases: conservation and divergence in their functions and regulation
    • Archambault V., Glover D.M. Polo-like kinases: conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell Biol. 2009, 10(4):265-275.
    • (2009) Nat. Rev. Mol. Cell Biol. , vol.10 , Issue.4 , pp. 265-275
    • Archambault, V.1    Glover, D.M.2
  • 31
    • 13244269808 scopus 로고    scopus 로고
    • Polo-like kinases and oncogenesis
    • Eckerdt F., Yuan J., Strebhardt K. Polo-like kinases and oncogenesis. Oncogene 2005, 24(2):267-276.
    • (2005) Oncogene , vol.24 , Issue.2 , pp. 267-276
    • Eckerdt, F.1    Yuan, J.2    Strebhardt, K.3
  • 33
    • 77955167321 scopus 로고    scopus 로고
    • Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
    • Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 2010, 9(8):643-660.
    • (2010) Nat. Rev. Drug Discov. , vol.9 , Issue.8 , pp. 643-660
    • Strebhardt, K.1
  • 34
    • 4344718620 scopus 로고    scopus 로고
    • Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis
    • van Vugt M.A., van de Weerdt B.C., Vader G., Janssen H., Calafat J., Klompmaker R., Wolthuis R.M., Medema R.H. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J. Biol. Chem. 2004, 279(35):36841-36854.
    • (2004) J. Biol. Chem. , vol.279 , Issue.35 , pp. 36841-36854
    • van Vugt, M.A.1    van de Weerdt, B.C.2    Vader, G.3    Janssen, H.4    Calafat, J.5    Klompmaker, R.6    Wolthuis, R.M.7    Medema, R.H.8
  • 38
    • 70350348676 scopus 로고    scopus 로고
    • The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
    • Zhang Y., Liu Y., Yang Y.X., Xia J.H., Zhang H.X., Li H.B., Yu C.Z. The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity. J. Exp. Clin. Cancer Res. 2009, 28(1):130.
    • (2009) J. Exp. Clin. Cancer Res. , vol.28 , Issue.1 , pp. 130
    • Zhang, Y.1    Liu, Y.2    Yang, Y.X.3    Xia, J.H.4    Zhang, H.X.5    Li, H.B.6    Yu, C.Z.7
  • 39
    • 33646551185 scopus 로고    scopus 로고
    • Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells
    • Schmidt M., Hofmann H.P., Sanders K., Sczakiel G., Beckers T.L., Gekeler V. Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells. Mol. Cancer Ther. 2006, 5(4):809-817.
    • (2006) Mol. Cancer Ther. , vol.5 , Issue.4 , pp. 809-817
    • Schmidt, M.1    Hofmann, H.P.2    Sanders, K.3    Sczakiel, G.4    Beckers, T.L.5    Gekeler, V.6
  • 40
    • 34548183782 scopus 로고    scopus 로고
    • Rational combinations of siRNAs targeting Plk1 with breast cancer drugs enhanced drug sensitivity by Plk1-specific siRNA
    • Spänkuch B., Kurunci-Csacsko E., Kaufmann M., Strebhardt K. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs enhanced drug sensitivity by Plk1-specific siRNA. Oncogene 2007, 26(39):5793-5807.
    • (2007) Oncogene , vol.26 , Issue.39 , pp. 5793-5807
    • Spänkuch, B.1    Kurunci-Csacsko, E.2    Kaufmann, M.3    Strebhardt, K.4
  • 41
    • 79951914745 scopus 로고    scopus 로고
    • Simultaneous delivery of siRNA and paclitaxel via a two-in-one micelleplex promotes synergistic tumor suppression
    • Sun T.M., Du J.Z., Yao Y.D., Mao C.Q., Dou S., Huang S.Y., Zhang P.Z., Leong K.W., Song E.W., Wang J. Simultaneous delivery of siRNA and paclitaxel via a two-in-one micelleplex promotes synergistic tumor suppression. ACS Nano. 2011, 5(2):1483-1494.
    • (2011) ACS Nano. , vol.5 , Issue.2 , pp. 1483-1494
    • Sun, T.M.1    Du, J.Z.2    Yao, Y.D.3    Mao, C.Q.4    Dou, S.5    Huang, S.Y.6    Zhang, P.Z.7    Leong, K.W.8    Song, E.W.9    Wang, J.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.